UNQUOTE

UK - Sitka Health Fund VCT plc announces positive performance

  • Rob
  • LinkedIn  
  • Google plus  

Sitka Ltd, manager of the Sitka Health Fund VCT (Sitka VCT) has announced results for the year ending 31st January 2006, with the net asset value per ordinary share reaching 89.7p. It has invested a total of ТЃ7.2m in 16 different companies and has managed a 5p per share return to investors since inception.

Sitka VCT raised £7m when Genosis was listed on the AIM market in December 2005, the price of shares in Immunodiagnostic Systems has risen 135% since the investment in December 2004. Within their private portfolio, Altrix has increased profitability by 146% to £700,000 and Inforsense’s turnover for the year up to March 2005 is reported to be 308% higher than the previous year.

The Sitka Health Fund VCT is one of 4 funds managed by Noble Fund Managers, a venture capital company and is led by 16 investment professionals. Due to changes in VCT legislation, Sitka VCT will not be able to invest in companies with gross assets greater than £7m instead of £15m, but this will not show a huge impact as most of the companies in Sitka VCT’s portfolio are less than £7m.

  • LinkedIn  
  • Google plus  

More on UK / Ireland

Latest News